McKesson 2010 Annual Report Download - page 9

Download and view the complete annual report

Please find page 9 of the 2010 McKesson annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 128

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128

McKESSON CORPORATION
3
PART I
Item 1. Business
General
McKesson Corporation (“McKesson,” the “Company,” the “Registrant” or “we” and other similar pronouns), is
a Fortune 14 corporation that delivers medicines, pharmaceutical supplies, information and care management
products and services designed to reduce costs and improve quality across the healthcare industry.
The Company’s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references in
this document to a particular year shall mean the Company’s fiscal year.
Our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and
amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of
1934, as amended (the “Exchange Act,”) are available free of charge on our Web site (www.mckesson.com under
the “Investors – Financial Information – SEC Filings” caption) as soon as reasonably practicable after we
electronically file such material with, or furnish it to, the Securities and Exchange Commission (“SEC” or the
“Commission”). The content on any Web site referred to in this Annual Report on Form 10-K is not incorporated by
reference into this report, unless expressly noted otherwise.
The public may also read or copy any materials that we file with the SEC at the SEC’s Public Reference Room
at 100 F Street, NW, Washington, D.C. 20549. The public may obtain information on the operation of the Public
Reference Room by calling the SEC at 1-800-SEC-0330. The SEC maintains a website that contains reports, proxy
and information statements, and other information regarding issuers, including the Company, that file electronically
with the SEC. The address of the website is http://www.sec.gov.
Business Segments
We operate in two segments. The McKesson Distribution Solutions segment distributes ethical and proprietary
drugs, medical-surgical supplies and equipment and health and beauty care products throughout North America.
This segment also provides specialty pharmaceutical solutions for biotech and pharmaceutical manufacturers, sells
financial, operational and clinical solutions for pharmacies (retail, hospital, long-term care) and provides consulting,
outsourcing and other services. This segment includes a 49% interest in Nadro, S.A. de C.V. (“Nadro”), one of the
leading pharmaceutical distributors in Mexico and a 39% interest in Parata Systems, LLC (“Parata”), which sells
automated pharmacy and supply management systems and services to retail and institutional outpatient pharmacies.
The McKesson Technology Solutions segment delivers enterprise-wide clinical, patient care, financial, supply
chain, strategic management software solutions, pharmacy automation for hospitals, as well as connectivity,
outsourcing and other services, including remote hosting and managed services, to healthcare organizations. This
segment also includes our Payor group of businesses, which includes our InterQual® claims payment solutions,
medical management software businesses and our care management programs. The segment’s customers include
hospitals, physicians, homecare providers, retail pharmacies and payors from North America, the United Kingdom,
Ireland, other European countries, Asia Pacific and Israel.
Net revenues for our segments for the last three years were as follows:
(Dollars in billions) 2010 2009 2008
Distribution Solutions $ 105.6 97% $ 103.6 97% $ 98.7 97%
Technology Solutions 3.1 3% 3.0 3% 3.0 3%
Total $ 108.7 100% $ 106.6 100% $ 101.7 100%